Dear Madam,
Dear Sir,
UCB will present the first detailed Phase III Clinical Study Results of Cimzia(TM) for the treatment of Crohn's disease (PRECISE 2) on Tuesday October 18, 2005 in Copenhagen, Denmark.
Please find hereunder a hyperlink to an invitation to a presentation/conference call, which will be held on this occasion:
Looking forward to hearing from you,
Sincerely yours,
Jean-Christophe Donck
Vice President Corporate Communication
and Investor Relations
Tel.: +32 2 559 9588